Chem-/Biotech

Digital all-rounder for lipoedema

LipoCheck GmbH

LipoCheck GmbH is a healthtech company specializing in improving the diagnosis and treatment of lipedema. The founding team combines many years of medical expertise with experience in developing digital products and artificial intelligence. LipoCheck is developing a digital health platform that offers AI-powered early detection, diagnosis, and daily support for lipedema patients. The goal is to close the care gap for this chronic, often underdiagnosed condition and provide patients with a reliable, low-threshold point of contact.

TGFS has held a stake in the company since 2025.

Status
Active

Segment
Early stage

Headquarter
Leipzig

Website
www.lipocheck.de

TGFS-Team
Oliver Latz
Tobias Voigt

Company news

TGFS participates in LipoCheck

10. Mar. 2025

As lead investor, TGFS is investing in LipoCheck GmbH, a start-up based in Leipzig. The funds from this round will be used to expand and internationalize the digital health platform, which focuses on the topic of lipedema.